http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2529865-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_639573561c8376e88a1a88c5f02b929e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1169cce02066e088dda8a74beecb68b3 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5025 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025 |
| filingDate | 2013-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e60bcf189c994c0357508a29660e68f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f0b0e51f57b6fec7daec3db791c97fa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb22b3ffe20e2b07b2ac486a5a102bc7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdf228ec9f8dd2d9362a19735876d67f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08961a0450671adc190b2502570b7f7e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ef9d27fa8c50e37302fd33ed7b089c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f26bb33addb215fa5f9f07b1b3c2364 |
| publicationDate | 2015-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2529865-B1 |
| titleOfInvention | USE OF COMPOUNDS DERIVED FROM SIRES OF PIRIDAZINO [1 ', 6': 1,2] PIRIDO [3,4-b] INDOLINIO AS ANTI-INFLAMMATORY AGENTS |
| abstract | Use of compounds derived from pyridazine salts [1 ', 6': 1,2] pyrido [3,4-b] indolinium as anti-inflammatory agents. # The present invention relates to compounds of the families of pyridazinopyridoindolinium salts, with pharmaceutical compositions containing them and with the use thereof as anti-inflammatory agents through the inhibition of the production of tumor necrosis factor alpha (TNF-al) by monocytes and pro-inflammatory macrophages in mammals and in all diseases and conditions in which this mediator has elevated levels, such as rheumatoid arthritis, osteoarthritis, Crohn's disease, ulcerative colitis, asthma, bronchitis, chronic obstructive airways disease, psoriasis, allergic rhinitis, ankylosing spondylitis, suppurative hydradenitis, dermatitis and any other inflammatory state with high levels of TNF- {al}. |
| priorityDate | 2013-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 104.